1. European Medicines Agency & Committee for Medicinal Products for Human Use (EMEA CHMP). Guideline on the clinical development of medicinal products for the treatment of cystic fibrosis. London: EMEA CHMP; 2008.
2. Monitoring Exercise in Children and Adolescents with Cystic Fibrosis: Validation of the CSA Accelerometer
3. National Institute for Health and Clinical Excellence (NICE). Four commonly used methods to increase physical activity: brief inventions in primary care, exercise referral schemes, pedometers and community-based exercise programmes for walking and cycling. London: NICE; March 2006.